New Zealand had fewer deaths in 2020 than expected

Publicly released:
New Zealand; International
PHOTO: Guillaume Lebelt/Unsplash
PHOTO: Guillaume Lebelt/Unsplash

Almost one million more people died than expected last year in 29 high-income countries, according to a large study that estimated how the COVID-19 pandemic affected death rates. New Zealand stood out as the only country studied that had fewer actual deaths than expected - about 2,500 in total. New Zealand managed to keep deaths below the anticipated level in all age groups, and for both men and women. An especially marked reduction in deaths was also observed for older Kiwis. The authors note that our pandemic success may be attributed to our early elimination strategy.

News release

From: The BMJ

Study finds almost 1 million extra deaths in 29 high income countries in 2020

Including 94,400 more deaths than expected in the UK alone

Almost 1 million extra deaths relating to the covid-19 pandemic occurred in 29 high income countries in 2020, finds a study published by The BMJ today.

Except for Norway, Denmark and New Zealand, all other countries examined had more deaths than expected in 2020, particularly in men. The five countries with the highest absolute number of excess deaths were the US, UK, Italy, Spain, and Poland.

Measuring excess deaths - the number of deaths above that expected during a given time period - is a way of assessing the impact of the pandemic on deaths in different populations. However, previous studies have not accounted for temporal and seasonal trends and differences in age and sex across countries.

To address this, a team of international researchers, led by Dr Nazrul Islam from the Nuffield Department of Population Health, University of Oxford, set out to estimate the direct and indirect effects of the covid-19 pandemic on mortality in 2020 in 29 high income countries.

Using a mathematical model, they calculated weekly excess deaths in 2020 for each country, accounting for age and sex differences between countries, and also for seasonal and yearly trends in mortality over the five preceding years.

Overall an estimated 979,000 total excess deaths occurred in 2020 in the 29 countries analysed. All countries experienced excess deaths in 2020, except New Zealand, Norway, and Denmark.

The five countries with the highest absolute number of excess deaths were the US (458,000), the UK (94,400), Italy (89,100), Spain (84,100), and Poland (60,100). New Zealand had lower overall deaths than expected (−2,500).

The total number of excess deaths was largely concentrated among people aged 75 or older, followed by people aged 65-74, while deaths in children under 15 were similar to expected levels in most countries and lower than expected in some countries.

In most countries, the estimated number of excess deaths exceeded the number of reported deaths from covid-19. For example, in both the US and the UK, estimated excess deaths were more than 30% higher than the number of reported covid-19 deaths.

However, other countries such as Israel and France had a higher number of reported covid-19 deaths than estimated excess deaths. The cause of this variation is unclear, but may result from access to testing and differences in how countries define and record covid-19 deaths.

In most countries, age specific excess death rates were higher in men than in women, and the absolute difference in rates between the sexes tended to increase with age. However, in the US the excess death rate was higher among women than men in those aged 85 years or older.

The researchers point to some study limitations, including a lack of data from lower and middle income countries and on factors such as ethnicity and socioeconomic status, and they acknowledge that many indirect effects of a pandemic may need a longer timeframe to have a measurable effect on mortality.

Nevertheless, this was a large study using detailed age and sex specific mortality data with robust analytical methods, and as such “adds important insights on the direct and indirect effects of the covid-19 pandemic on total mortality,” they say.

“Reliable and timely monitoring of excess deaths would help to inform public health policy in investigating the sources of excess mortality in populations and would help to detect important social inequalities in the impact of the pandemic to inform more targeted interventions,” they add.

Future work will also be needed to understand the impact of national vaccination programmes on mortality in 2021, they conclude.

These findings confirm the huge toll of the covid-19 pandemic on mortality in high-income countries in 2020, say researchers at Imperial College London in a linked editorial.

But they warn that its full impact may not be apparent for many years, particularly in lower income countries where factors such as poverty, lack of vaccines, weak health systems, and high population density place people at increased risk from covid-19 and related harm.

And they point out that while mortality is a useful metric, policy informed by deaths alone overlooks what may become a huge burden of long-term morbidity resulting from covid-19.

“There is an urgent need to measure this excess morbidity, support those with long-term complications of covid-19, and fund health systems globally to address the backlog of work resulting from the pandemic,” they conclude.

[Ends]

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research The BMJ, Web page Public weblink to research after embargo lifts
Editorial / Opinion The BMJ, Web page Public link to editorial after embargo lifts
Journal/
conference:
British Medical Journal
Research:Paper
Organisation/s: University of Oxford (UK), University of Cambridge (UK), Max Planck Institute for Demographic Research (Germany), National Research University Higher School of Economics (Russian Federation), Harvard University (US)
Funder: Funding: No specific funding was received for this study. NI receives salary support from the Nuffield Department of Population Health (NDPH), University of Oxford. BL acknowledges support from UK Biobank, the NIHR Oxford Biomedical Research Centre, and the BHF Centre of Research Excellence, Oxford. MW is supported by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration (UKCRC) Public Health Research Centre of Excellence Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council (MRC), National Institute for Health Research (NIHR), and Wellcome Trust, under the auspices of the UKCRC. MW is also supported by the MRC (grant Nos MC_UU_12015/6 and MC_UU_00006/7). IKlimkin was fully supported, and VMS and JDA were partially supported, by the Basic Research Program of the National Research University Higher School of Economics. RAI and RJA are supported by the National Institutes of Health (R35GM131802 and T32ES007142, respectively). KK and TY are supported by the NIHR Applied Research Collaboration East Midlands (ARC EM) and the NIHR Leicester Biomedical Research Centre (BRC). Covid-19 research by TY is supported by the NIHR Leicester BRC and grants from the UKRI (MRC)-DHSC (NIHR) COVID-19 Rapid Response Rolling Call (MR/ V020536/1) and from HDR-UK (HDRUK2020.138). The BMJ open access fee was supported by research funding from the US Centers for Disease Control and Prevention Foundation (with support from Amgen). Employers/sponsors had no role in the design, analysis, or dissemination of the study. The views expressed in this article are those of the authors and not necessarily those of the entities the authors are affiliated with and/or supported by. Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no specific funding was received for this study; the BMJ open access fee was supported by research funding from the US Centers for Disease Control and Prevention Foundation (with support from Amgen); SL reports grants from the MRC and research funding from the US Centers for Disease Control and Prevention Foundation (with support from Amgen); MW reports research funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, MRC, NIHR, and Wellcome Trust unrelated to this study; NI, SL, and VMS are members of the WHO-UN DESA Technical Advisory Group on covid-19 mortality assessment; KK is a member of the UK Scientific Advisory Group for Emergency (SAGE) and Independent SAGE; no other relationships or activities that could appear to have influenced the submitted work.
Media Contact/s
Contact details are only visible to registered journalists.